ATBPF Antibe Therapeutics Inc

USD 0.22 0.00 ( 0.00%)
Icon

Antibe Therapeutics Inc (ATBPF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.22

0.00 (0.00%)

USD 0.01B

N/A

N/A

N/A

Icon

ATBPF

Antibe Therapeutics Inc (USD)
COMMON STOCK | OTC
USD 0.22
0.00 ( 0.00%)
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.01B

N/A

USD 0.22

Antibe Therapeutics Inc (ATBPF) Stock Forecast

N/A

Based on the Antibe Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Antibe Therapeutics Inc is not available over the next 12 months. Antibe Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Antibe Therapeutics Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Antibe Therapeutics Inc’s stock price was USD 0.22. Antibe Therapeutics Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Antibe Therapeutics Inc
No recent average analyst rating found for Antibe Therapeutics Inc

Company Overview Antibe Therapeutics Inc

Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that s...Read More

https://www.antibethera.com

15 Prince Arthur Avenue, Toronto, ON, Canada, M5R 1B2

11

March

USD

USA

Adjusted Closing Price for Antibe Therapeutics Inc (ATBPF)

Loading...

Unadjusted Closing Price for Antibe Therapeutics Inc (ATBPF)

Loading...

Share Trading Volume for Antibe Therapeutics Inc Shares

Loading...

Compare Performance of Antibe Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ATBPF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Antibe Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ARGNF
argenx SE 0.00 (0.00%) USD42.54B 54.66 301.51

Frequently Asked Questions About Antibe Therapeutics Inc (ATBPF) Stock

Stock Target Advisor's fundamental analysis for Antibe Therapeutics Inc's stock is Bearish.

Unfortunately we do not have enough data on ATBPF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ATBPF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ATBPF's stock to indicate if its overvalued.

The last closing price of ATBPF's stock was USD 0.22.

The most recent market capitalization for ATBPF is USD 0.01B.

Unfortunately we do not have enough analyst data on ATBPF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Antibe Therapeutics Inc's stock.

As per our most recent records Antibe Therapeutics Inc has 11 Employees.

Antibe Therapeutics Inc's registered address is 15 Prince Arthur Avenue, Toronto, ON, Canada, M5R 1B2. You can get more information about it from Antibe Therapeutics Inc's website at https://www.antibethera.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Antibe Therapeutics Inc (ATBPF) Stock

Stock Target Advisor's fundamental analysis for Antibe Therapeutics Inc's stock is Bearish.

Unfortunately we do not have enough data on ATBPF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ATBPF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ATBPF's stock to indicate if its overvalued.

The last closing price of ATBPF's stock was USD 0.22.

The most recent market capitalization for ATBPF is USD 0.01B.

Unfortunately we do not have enough analyst data on ATBPF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Antibe Therapeutics Inc's stock.

As per our most recent records Antibe Therapeutics Inc has 11 Employees.

Antibe Therapeutics Inc's registered address is 15 Prince Arthur Avenue, Toronto, ON, Canada, M5R 1B2. You can get more information about it from Antibe Therapeutics Inc's website at https://www.antibethera.com.
Loading...